secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001746473-23-000062
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics signs 7-year lease for 100,904 sq ft in South San Francisco, terminates old lease
--------------------------------------------------------------------------------

- Leased 100,904 rentable sq ft at 331 Oyster Point Blvd, South San Francisco for 7-year initial term.
- Base rent starts at $0.26M/month in year 1 (based on phased rentable sq ft) and rises to $0.71M/month in year 7.
- Old lease at 260 Littlefield Ave will terminate 60 days after new lease commencement; no early termination penalties.
- Required $1.43M letter of credit; Tenant responsible for operating expenses and has 8-year extension option.
- Right of first offer on 33,333 sq ft on 2nd floor, subject to superior right of NGM Biopharmaceuticals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000174647323000062/0001746473-23-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000174647323000062/plrx-20230928.htm
  HTML page:      https://secwatch.observer/filing/0001746473-23-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer